Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 131Genitourinary 15Gastrointestinal 15Head & Neck 8Gynecologic 7Breast 7Sarcoma 5Dermatologic 5CNS 5Lymphoid 4Endocrine 4Other solid neoplasm 2Other 2NET 2Other hematologic neoplasm 1Myeloid 1

Conditions

Lymphoma 2981Precursor Cell Lymphoblastic Leukemia-Lymphoma 2496Lymphoma, Non-Hodgkin 2265Leukemia, Lymphocytic, Chronic, B-Cell 1992Lymphoma, Follicular 1847Lymphoma, Large B-Cell, Diffuse 1784Leukemia 1339Hodgkin Disease 1292Lymphoma, Mantle-Cell 1193Leukemia, Myeloid, Acute 978Burkitt Lymphoma 955Multiple Myeloma 866Lymphoma, B-Cell, Marginal Zone 853Recurrence 839Lymphoma, B-Cell 754Myelodysplastic Syndromes 682Neoplasms 593Lymphoma, T-Cell, Cutaneous 543Waldenstrom Macroglobulinemia 514Lymphoma, Large-Cell, Immunoblastic 490Mycosis Fungoides 438Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 414Lymphoma, Large-Cell, Anaplastic 390Sezary Syndrome 364Lymphoma, T-Cell, Peripheral 350Hematologic Neoplasms 350Leukemia, Myelogenous, Chronic, BCR-ABL Positive 334Myeloproliferative Disorders 328Neoplasms, Plasma Cell 309Blast Crisis 284

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Lung Diseases × Lymphoid × Clear all
NCT03613363 2025-06-06

Engineering Evaluation of the Helix Ventilator

Philips Respironics

Phase NA Completed
20 enrolled 9 charts
LymphoidOther hematologic neoplasm

Lung Diseases, Respiration Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00210249 2022-02-04

PHRC2003

Institut Bergonié

Completed
364 enrolled 4 charts
GenitourinaryGynecologicLymphoid

Urinary Bladder Diseases, Digestive System Diseases, Lung Diseases, Lymphoma, Neoplasms, Ovarian Diseases, Prostatic Diseases

NCT04982042 2021-08-04

COVID19REHAB

Centro Universitário de Anapolis

Phase NA Unknown
40 enrolled
Lymphoid

COVID-19, Anxiety Disorders, Lung Diseases, Lymphoma, Follicular, Respiratory Insufficiency, Muscle Weakness

NCT00923520 2018-12-05

A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
60 enrolled
BreastGastrointestinalGenitourinaryLymphoidThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Diseases, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡